Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Drug Test Anal ; 5(4): 266-9, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23355217

RESUMO

The use of formoterol in sports is allowed by inhalation at the maximum recommended therapeutic dose. Recently, a threshold concentration of 30 ng.mL(-1) was defined by the World Anti-Doping Agency (WADA) to distinguish between therapeutic and forbidden use of formoterol. The objective of this work was to evaluate that threshold concentration. Concentrations of formoterol were measured in urine samples collected after administration of 18 µg of inhaled formoterol to five healthy volunteers, and in samples collected in routine doping tests belonging to athletes having declared inhaled formoterol use. Formoterol was detected up to 8 h after administration in all volunteers with concentrations up to 19.6 ng.mL(-1) . From 28 routine samples, 27 had less than 10 ng.mL(-1) of formoterol and only in one of the samples the concentration was 25 ng.mL(-1) . Therefore, administration of formoterol by inhalation at the maximum dose allowed by WADA will not produce false positive results using a threshold concentration of 30 ng.mL(-1) , and the experience up to now in routine doping tests indicates that the probability of obtaining urines with concentrations greater than 30 ng.mL(-1) is close to nil. For this reason, sports authorities should re-evaluate the need of a threshold concentration for formoterol and its practical usefulness.


Assuntos
Agonistas de Receptores Adrenérgicos beta 2/urina , Broncodilatadores/urina , Etanolaminas/urina , Detecção do Abuso de Substâncias/métodos , Administração por Inalação , Agonistas de Receptores Adrenérgicos beta 2/administração & dosagem , Broncodilatadores/administração & dosagem , Dopagem Esportivo , Etanolaminas/administração & dosagem , Feminino , Fumarato de Formoterol , Humanos , Masculino , Sensibilidade e Especificidade
2.
CNS Spectr ; 11(4): 262-4, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16641831

RESUMO

OBJECTIVE: To describe a case of marijuana-induced delirium and the techniques used to detect psychoactive agents and metabolites in urine. METHODS: A case of delirium following involuntary ingestion of cannabis is described. A urine sample was analyzed applying various chemical procedures, using high-resolution gas chromatography coupled with mass spectrometry technique. 11-Nor-delta9-tetrahydrocannabinol-9-carboxylic acid was quantified by the methodology for steroids and cannabis. RESULTS: A 26-year-old man was hospitalized with severe agitation and psychotic behavior 36 hours after suspected involuntary ingestion of cannabis contained in a brigadeiro, a typical Brazilian cookie, consumed during a party. Treatment with neuroleptics resulted in complete regression of the symptoms over 2 weeks. The urine sample revealed marijuana ingestion, demonstrated by the presence of its metabolite, 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in high concentration. No other investigated substance was found in the patient's urine. CONCLUSION: Severe delirium can follow oral ingestion of cannabis integrated into homemade cookies.


Assuntos
Cacau , Cannabis/toxicidade , Delírio/induzido quimicamente , Contaminação de Alimentos , Psicoses Induzidas por Substâncias/etiologia , Adulto , Delírio/diagnóstico , Diagnóstico Diferencial , Dronabinol/análogos & derivados , Dronabinol/urina , Contaminação de Alimentos/análise , Humanos , Masculino , Taxa de Depuração Metabólica/fisiologia , Psicoses Induzidas por Substâncias/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA